These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2752498)

  • 1. Immuno-affinity purification of specific antibodies against vasoactive intestinal polypeptide (VIP) on VIP (1-10)-linked polydimethylacrylamide resin.
    Takeyama M; Hatano M; Otaka A; Fujii N; Yajima H
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):834-7. PubMed ID: 2752498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immuno-affinity purification of specific antibodies against human gastrin releasing peptide (h-GRP) by the h-GRP(1-8)-linked polydimethylacrylamide resin.
    Takeyama M; Kino T; Guo LL; Otaka A; Fujii N; Yajima H
    Int J Pept Protein Res; 1989 Jun; 33(6):457-62. PubMed ID: 2777478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity chromatography of catalytic autoantibody to vasoactive intestinal peptide.
    Paul S; Volle DJ; Mei S
    J Immunol; 1990 Aug; 145(4):1196-9. PubMed ID: 2380555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Micro-enzyme immunoassay of vasoactive intestinal polypeptide (VIP)-like immunoreactive substance in bovine milk.
    Takeyama M; Wakayama K; Takayama F; Kondo K; Fujii N; Yajima H
    Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):960-2. PubMed ID: 2199087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against vasoactive intestinal polypeptide: studies of structure and related antigens.
    Gozes I; Milner RJ; Liu FT; Johnson E; Battenberg EL; Katz DH; Bloom FE
    J Neurochem; 1983 Aug; 41(2):549-55. PubMed ID: 6875552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, cloning and expression in Escherichia coli of artificial genes coding for biologically active elongated precursors of the vasoactive intestinal polypeptide.
    Simoncsits A; Tjörnhammar ML; Kalman M; Cserpan I; Gafvelin G; Bartfai T
    Eur J Biochem; 1988 Dec; 178(2):343-50. PubMed ID: 3145201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catalytic hydrolysis of vasoactive intestinal peptide by human autoantibody.
    Paul S; Volle DJ; Beach CM; Johnson DR; Powell MJ; Massey RJ
    Science; 1989 Jun; 244(4909):1158-62. PubMed ID: 2727702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma.
    Fahrenkrug J; Schaffalitzky de Muckadell OV
    J Lab Clin Med; 1977 Jun; 89(6):1379-88. PubMed ID: 325156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding and multiple hydrolytic sites in epitopes recognized by catalytic anti-peptide antibodies.
    Paul S; Johnson DR; Massey R
    Ciba Found Symp; 1991; 159():156-67; discussion 167-73. PubMed ID: 1720373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Site specificity of a catalytic vasoactive intestinal peptide antibody. An inhibitory vasoactive intestinal peptide subsequence distant from the scissile peptide bond.
    Paul S; Volle DJ; Powell MJ; Massey RJ
    J Biol Chem; 1990 Jul; 265(20):11910-3. PubMed ID: 2365706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different vasoactive intestinal polypeptide receptor domains are involved in the selective recognition of two VPAC(2)-selective ligands.
    Juarranz MG; Van Rampelbergh J; Gourlet P; De Neef P; Cnudde J; Robberecht P; Waelbroeck M
    Mol Pharmacol; 1999 Dec; 56(6):1280-7. PubMed ID: 10570056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide is a physiological mediator of prolactin release in the rat.
    Abe H; Engler D; Molitch ME; Bollinger-Gruber J; Reichlin S
    Endocrinology; 1985 Apr; 116(4):1383-90. PubMed ID: 4038645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of rat vasoactive intestinal peptide.
    Dimaline R; Reeve JR; Shively JE; Hawke D
    Peptides; 1984; 5(2):183-7. PubMed ID: 6473151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen recognition by an antibody light chain.
    Sun M; Li L; Gao QS; Paul S
    J Biol Chem; 1994 Jan; 269(1):734-8. PubMed ID: 8276876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage specificity of a proteolytic antibody light chain and effects of the heavy chain variable domain.
    Sun M; Gao QS; Kirnarskiy L; Rees A; Paul S
    J Mol Biol; 1997 Aug; 271(3):374-85. PubMed ID: 9268666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effects of vasoactive intestinal peptide (VIP) on leucocyte migration.
    Bondesson L; Norolind K; Lidén S; Gafvelin G; Theodorsson E; Mutt V
    Acta Physiol Scand; 1991 Apr; 141(4):477-81. PubMed ID: 1877347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidolytic monoclonal antibody elicited by a neuropeptide.
    Paul S; Sun M; Mody R; Tewary HK; Stemmer P; Massey RJ; Gianferrara T; Mehrotra S; Dreyer T; Meldal M
    J Biol Chem; 1992 Jul; 267(19):13142-5. PubMed ID: 1377678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal polypeptide carboxy-terminal fragment, VIP(22-28), and other fragments of VIP, in the central nervous system of the rat.
    Romualdi P; Rosenberger JG; Gozzini L; Cox BM
    Peptides; 1989; 10(3):621-6. PubMed ID: 2780421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation.
    Hashimoto H; Ogawa N; Hagihara N; Yamamoto K; Imanishi K; Nogi H; Nishino A; Fujita T; Matsuda T; Nagata S; Baba A
    Mol Pharmacol; 1997 Jul; 52(1):128-35. PubMed ID: 9224822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibody to vasoactive intestinal peptide in human circulation.
    Paul S; Heinz-Erian P; Said SI
    Biochem Biophys Res Commun; 1985 Jul; 130(1):479-85. PubMed ID: 3839670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.